Cargando…

Development of algorithms to identify individuals with Neurofibromatosis type 1 within administrative data and electronic medical records in Ontario, Canada

BACKGROUND: There is limited population-based data on Neurofibromatosis type 1 (NF1) in North America. We aimed to develop and validate algorithms using administrative health data and electronic medical records (EMRs) to identify individuals with NF1 in Ontario, Canada. METHODS: We conducted an elec...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnett, Carolina, Candido, Elisa, Chen, Branson, Pequeno, Priscila, Parkin, Patricia C., Tu, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419337/
https://www.ncbi.nlm.nih.gov/pubmed/36028856
http://dx.doi.org/10.1186/s13023-022-02493-5
_version_ 1784777153668186112
author Barnett, Carolina
Candido, Elisa
Chen, Branson
Pequeno, Priscila
Parkin, Patricia C.
Tu, Karen
author_facet Barnett, Carolina
Candido, Elisa
Chen, Branson
Pequeno, Priscila
Parkin, Patricia C.
Tu, Karen
author_sort Barnett, Carolina
collection PubMed
description BACKGROUND: There is limited population-based data on Neurofibromatosis type 1 (NF1) in North America. We aimed to develop and validate algorithms using administrative health data and electronic medical records (EMRs) to identify individuals with NF1 in Ontario, Canada. METHODS: We conducted an electronic free-text search of 15 commonly-used terms related to NF1 in the Electronic Medical Records Primary Care Database. Records were reviewed by two trained abstractors who classified them as confirmed, possible, and not NF1. An investigator with clinical expertise performed final NF1 classification. Patients were classified as confirmed if there was a documented diagnosis, meeting NIH criteria. Patients were classified as possible if (1) NF1 was recorded in the cumulative patient profile, but no clinical information to support the diagnosis; (2) only one criterion for diagnosis (e.g. child of confirmed case) but no further data to confirm or rule out. We tested different combinations of outpatient and inpatient billing codes, and applied a free-text search algorithm to identify NF1 cases in administrative data and EMRs, respectively. RESULTS: Of 273,440 eligible patients, 2,058 had one or more NF1 terms in their medical records. The terms “NF”, “café-au-lait”, or “sheath tumour” were constrained to appear in combination with another NF1 term. This resulted in 837 patients: 37 with possible and 71 with confirmed NF1. The population prevalence ranged from 1 in 3851 (confirmed NF1) to 1 in 2532 (possible and confirmed NF1). Billing code algorithms had poor performance, with overall low PPV (highest being 71%). The accuracy of the free-text EMR algorithm in identifying patients with NF1 was: sensitivity 85% (95% CI 74–92%), specificity 100% (95% CI 100–100%), positive predictive value 80% (95% CI 69–88%), negative predictive value 100% (95% CI 100–100%), and false positive rate 20% (95% CI 11–33%). Of false positives, 53% were possible NF1. CONCLUSIONS: A free-text search algorithm within the EMR had high sensitivity, specificity and predictive values. Algorithms using billing codes had poor performance, likely due to the lack of NF-specific codes for outpatient visits. While NF1 ICD-9 and 10 codes are used for hospital admissions, only ~ 30% of confirmed NF1 cases had a hospitalization associated with an NF1 code.
format Online
Article
Text
id pubmed-9419337
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94193372022-08-28 Development of algorithms to identify individuals with Neurofibromatosis type 1 within administrative data and electronic medical records in Ontario, Canada Barnett, Carolina Candido, Elisa Chen, Branson Pequeno, Priscila Parkin, Patricia C. Tu, Karen Orphanet J Rare Dis Research BACKGROUND: There is limited population-based data on Neurofibromatosis type 1 (NF1) in North America. We aimed to develop and validate algorithms using administrative health data and electronic medical records (EMRs) to identify individuals with NF1 in Ontario, Canada. METHODS: We conducted an electronic free-text search of 15 commonly-used terms related to NF1 in the Electronic Medical Records Primary Care Database. Records were reviewed by two trained abstractors who classified them as confirmed, possible, and not NF1. An investigator with clinical expertise performed final NF1 classification. Patients were classified as confirmed if there was a documented diagnosis, meeting NIH criteria. Patients were classified as possible if (1) NF1 was recorded in the cumulative patient profile, but no clinical information to support the diagnosis; (2) only one criterion for diagnosis (e.g. child of confirmed case) but no further data to confirm or rule out. We tested different combinations of outpatient and inpatient billing codes, and applied a free-text search algorithm to identify NF1 cases in administrative data and EMRs, respectively. RESULTS: Of 273,440 eligible patients, 2,058 had one or more NF1 terms in their medical records. The terms “NF”, “café-au-lait”, or “sheath tumour” were constrained to appear in combination with another NF1 term. This resulted in 837 patients: 37 with possible and 71 with confirmed NF1. The population prevalence ranged from 1 in 3851 (confirmed NF1) to 1 in 2532 (possible and confirmed NF1). Billing code algorithms had poor performance, with overall low PPV (highest being 71%). The accuracy of the free-text EMR algorithm in identifying patients with NF1 was: sensitivity 85% (95% CI 74–92%), specificity 100% (95% CI 100–100%), positive predictive value 80% (95% CI 69–88%), negative predictive value 100% (95% CI 100–100%), and false positive rate 20% (95% CI 11–33%). Of false positives, 53% were possible NF1. CONCLUSIONS: A free-text search algorithm within the EMR had high sensitivity, specificity and predictive values. Algorithms using billing codes had poor performance, likely due to the lack of NF-specific codes for outpatient visits. While NF1 ICD-9 and 10 codes are used for hospital admissions, only ~ 30% of confirmed NF1 cases had a hospitalization associated with an NF1 code. BioMed Central 2022-08-26 /pmc/articles/PMC9419337/ /pubmed/36028856 http://dx.doi.org/10.1186/s13023-022-02493-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Barnett, Carolina
Candido, Elisa
Chen, Branson
Pequeno, Priscila
Parkin, Patricia C.
Tu, Karen
Development of algorithms to identify individuals with Neurofibromatosis type 1 within administrative data and electronic medical records in Ontario, Canada
title Development of algorithms to identify individuals with Neurofibromatosis type 1 within administrative data and electronic medical records in Ontario, Canada
title_full Development of algorithms to identify individuals with Neurofibromatosis type 1 within administrative data and electronic medical records in Ontario, Canada
title_fullStr Development of algorithms to identify individuals with Neurofibromatosis type 1 within administrative data and electronic medical records in Ontario, Canada
title_full_unstemmed Development of algorithms to identify individuals with Neurofibromatosis type 1 within administrative data and electronic medical records in Ontario, Canada
title_short Development of algorithms to identify individuals with Neurofibromatosis type 1 within administrative data and electronic medical records in Ontario, Canada
title_sort development of algorithms to identify individuals with neurofibromatosis type 1 within administrative data and electronic medical records in ontario, canada
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419337/
https://www.ncbi.nlm.nih.gov/pubmed/36028856
http://dx.doi.org/10.1186/s13023-022-02493-5
work_keys_str_mv AT barnettcarolina developmentofalgorithmstoidentifyindividualswithneurofibromatosistype1withinadministrativedataandelectronicmedicalrecordsinontariocanada
AT candidoelisa developmentofalgorithmstoidentifyindividualswithneurofibromatosistype1withinadministrativedataandelectronicmedicalrecordsinontariocanada
AT chenbranson developmentofalgorithmstoidentifyindividualswithneurofibromatosistype1withinadministrativedataandelectronicmedicalrecordsinontariocanada
AT pequenopriscila developmentofalgorithmstoidentifyindividualswithneurofibromatosistype1withinadministrativedataandelectronicmedicalrecordsinontariocanada
AT parkinpatriciac developmentofalgorithmstoidentifyindividualswithneurofibromatosistype1withinadministrativedataandelectronicmedicalrecordsinontariocanada
AT tukaren developmentofalgorithmstoidentifyindividualswithneurofibromatosistype1withinadministrativedataandelectronicmedicalrecordsinontariocanada